Triple Crown Ventures

Gaming and Technology, Recent Transactions, Uncategorized

◁ BACK

Triple Crown Ventures
Date: 2025
Deal: Acquisition of majority stake in Cannovum Health.
About the client: TCV is a specialist vehicle established to invest in and acquire businesses across the medical cannabis value chain.
About the transaction: Akur advised TCV on the acquisition of a majority stake in Cannovum Health, a licensed distributor of medical cannabis products in Germany.
Lead: David Shapton
<img alt=“

 

Warning: Trying to access array offset on int in /home/akur/public_html/wp-content/plugins/WPExpressPopup/wp-express-popup.php on line 72
 

Chris Young…

Chris is focused on listed closed-ended funds, specialising in both equity and debt capital fundraising. He has over 16 years’ experience in both sales and research. With relationships across many of the large institutional investors in the sector, he has worked across IPOs, secondary fundraisings, placings and sales. He began his career in the City as an investment funds analyst at Credit Lyonnais in 1999, and has subsequently held positions at Lazard Panmure Gordon, Arbuthnot Securities, and most recently as a specialist salesman within the investment funds team at Westhouse Securities. He is focused on private and public real estate and REITs, infrastructure and utilities, emerging markets, private equity and alternatives. Tel: +44 (0) 20 3780 8746 Mob: +44 (0) 7471 141 303 Email: cyoung@akur.co.uk